Moreover, DCLK knock-down by RNA-interference technology leads to the activation of a proapoptotic program in neuroblastoma cells (Verissimo et al., 2010) and to a reduction of NPCs during neocortical development in vivo (Vreugdenhil et al., 2007). The gene discussed is DCLK1; the disease is neuroblastoma.